Abstract

Thyroid function is closely related to leptin's secretion by the adipose tissue. In states of leptin-deficiency, the circadian rhythm of TSH is altered, leading to central hypothyroidism in animal models. In humans, central hypothyroidism has also been described in rare cases of congenital leptin deficiency. However, the thyroid phenotype in these cases is heterogeneous, with the occurrence of central hypothyroidism in a minority of cases. Here we describe thyroid function in four leptin-deficient humans (2 males aged 5 and 27, and 2 females aged 35 and 40), before and during leptin replacement with recombinant human methionyl leptin (r-metHuLeptin). The child was evaluated for four years, and the adults, for eight years. In addition, the adults were submitted to a brief withdrawal of leptin during six weeks in the sixth year. Our results show that, regardless of leptin replacement, our leptin-deficient patients have normal thyroid function. In spite of having an important role in regulating the hypothalamic-pituitary-thyroidal axis, leptin is not required for normal thyroid function.ClinicalTrials.gov Identifiers: NCT00659828 and NCT00657605

Highlights

  • The mechanisms underlying the connection between adipose signals and energy expenditure include the regulation of the synthesis and secretion of thyrotropin releasing hormone (TRH) by leptin, through the mediation of input from the arcuate nucleus to the TRH neurons in the paraventricular nucleus (PVN) [1]

  • The thyroid axis is indirectly regulated by leptin's actions on the melanocortin pathway, as alpha-melanocyte stimulating hormone (MSH)

  • In three children of Pakistani origin, thyroid function tests were within the normal range

Read more

Summary

Introduction

In leptin-deficient humans, different thyroid phenotypes have been reported. In three children of Pakistani origin, thyroid function tests were within the normal range (page number not for citation purposes) Thyroid Research 2009, 2:11 http://www.thyroidresearchjournal.com/content/2/1/11 before the start of recombinant human methionyl leptin (r-metHuLeptin) therapy, with a rise in free T4 (fT4) thereafter in all children, and an increase in T3 in the two youngest [5].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call